Literature DB >> 6330839

Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis.

J L Melnick.   

Abstract

Not all poliomyelitis-like paralytic illnesses can be attributed to polioviruses. Among the most recently recognized agents able to cause severe central nervous system disease with persistent flaccid paralysis is enterovirus type 71. In the 1969-1973 California outbreaks during which strains of this type were first reported, meningitis predominated, but cases of encephalitis were also seen. Outbreaks in different regions of the world followed. In some, hand-foot-and-mouth syndrome predominated; in others, meningitis; and in some, the clinical patterns were mixed. In the 1975 Bulgarian outbreak of greater than 705 cases, 149 patients developed paralysis and 44 others died. Enterovirus 71 was incriminated as the cause of the epidemic, in which infants and young children were the chief victims. The 1978 Hungarian epidemic of central nervous system disease was mixed, involving a tick-borne encephalitis virus among adults and enterovirus 71 among children. This newly recognized enterovirus is also significant in relation to polio vaccines. At some time, vaccine inevitably will be given to persons already incubating enterovirus 71 infection, who then may present with the paralytic syndrome due to the wild enterovirus. Such cases could be mistakenly designated as related to polio vaccine, particularly since many enterovirus 71 strains are difficult to isolate under conditions that would readily yield poliovirus isolates from the vaccine.

Entities:  

Mesh:

Year:  1984        PMID: 6330839     DOI: 10.1093/clinids/6.supplement_2.s387

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  47 in total

1.  Diverse apoptotic pathways in enterovirus 71-infected cells.

Authors:  Shih-Cheng Chang; Jing-Yi Lin; Lily Yen-cheng Lo; Mei-Ling Li; Shin-Ru Shih
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

Review 2.  Nucleic acid detection systems for enteroviruses.

Authors:  H A Rotbart
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

Review 3.  Acute Flaccid Paralysis and Enteroviral Infections.

Authors:  Ari Bitnun; E Ann Yeh
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

4.  Non-polio enteroviruses in acute flaccid paralysis.

Authors:  A Kapoor; A Ayyagari; T N Dhole
Journal:  Indian J Pediatr       Date:  2001-10       Impact factor: 1.967

5.  Receptors identified for hand, foot and mouth virus.

Authors:  Kunal P Patel; Jeffrey M Bergelson
Journal:  Nat Med       Date:  2009-07       Impact factor: 53.440

6.  High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis.

Authors:  M M Georgescu; F Delpeyroux; M Tardy-Panit; J Balanant; M Combiescu; A A Combiescu; S Guillot; R Crainic
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Mouse neuropathogenic poliovirus strains cause damage in the central nervous system distinct from poliomyelitis.

Authors:  M Gromeier; H H Lu; E Wimmer
Journal:  Microb Pathog       Date:  1995-04       Impact factor: 3.738

8.  Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene.

Authors:  Kok Keng Tee; Tommy Tsan-Yuk Lam; Yoke Fun Chan; Jon M Bible; Adeeba Kamarulzaman; C Y William Tong; Yutaka Takebe; Oliver G Pybus
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

9.  Epidemiology and clinical characteristics of acute flaccid paralysis associated with non-polio enterovirus isolation: the experience in the Americas.

Authors:  V Dietz; J Andrus; J M Olivé; S Cochi; C de Quadros
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

10.  Conformational plasticity of the 2A proteinase from enterovirus 71.

Authors:  Qixu Cai; Muhammad Yameen; Weihua Liu; Zhenting Gao; Yaozong Li; Xuanjia Peng; Yaxian Cai; Caiming Wu; Qian Zheng; Jian Li; Tianwei Lin
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.